
Vir Biotechnology Hits Day Low of $5.87 Amid Price Pressure
2025-10-30 19:30:26Vir Biotechnology, Inc. has faced notable challenges, with a significant stock decline and ongoing financial struggles, including a net profit drop and negative cash flow. Over the past three years, the company has underperformed compared to the S&P 500, leading to reduced stakeholder confidence and a small-cap market capitalization.
Read full news article
Vir Biotechnology, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
2025-10-27 15:49:09Vir Biotechnology, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock, currently priced at $5.98, has shown significant volatility over the past year, with a 52-week high of $14.45 and a low of $4.16. Its performance has lagged behind the S&P 500 over various timeframes.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






